For instance, FLT3ITD TET2 (1, 5), FLT3ITDDNMT3A (2), DNMT3A TET2 (6, 7), or FLT3ITD NPM1 (8) mutations frequently coexist in normal CN patients with AML (9–11). This evidence concerns the gene NPM1 and acute myeloid leukemia.